|
LNX2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.341800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.700300E-02 |
| Normal-vs-Stage2 |
1.135040E-01 |
| Normal-vs-Stage3 |
7.223500E-04 |
| Normal-vs-Stage4 |
5.351200E-04 |
| Stage1-vs-Stage2 |
8.493000E-01 |
| Stage1-vs-Stage3 |
2.791900E-02 |
| Stage1-vs-Stage4 |
1.951800E-02 |
| Stage2-vs-Stage3 |
2.013000E-01 |
| Stage2-vs-Stage4 |
1.357170E-01 |
| Stage3-vs-Stage4 |
6.402000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.166410E-02 |
| Normal-vs-AfricanAmerican |
1.556410E-01 |
| Normal-vs-Asian |
1.526040E-02 |
| Caucasian-vs-AfricanAmerican |
7.687200E-01 |
| Caucasian-vs-Asian |
6.922800E-01 |
| AfricanAmerican-vs-Asian |
5.856000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.915500E-03 |
| Normal-vs-Female |
3.133900E-02 |
| Male-vs-Female |
1.960220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.399500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.580900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.404900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.017600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.327190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.474100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.291800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.583600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.022400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.665000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.202200E-02 |
| Classical-VS-Follicular |
7.033600E-01 |
| Classical-VS-Other |
3.278200E-01 |
| Classical-VS-Normal |
4.498000E-02 |
| Tall-VS-Follicular |
2.074400E-01 |
| Tall-VS-Other |
8.041800E-01 |
| Tall-VS-Normal |
2.696700E-03 |
| Follicular-VS-Other |
4.841200E-01 |
| Follicular-VS-Normal |
4.702400E-02 |
| Other-VS-Normal |
6.211900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.408320E-02 |
| Normal-vs-N1 |
2.382600E-03 |
| N0-vs-N1 |
2.136400E-01 |
|
|
